STAT3 and neoplasm: Given all the available evidence, which showed that autophagy leads to elevated STAT3 activation favoring tumor cell survival and evading immune system, increased ability to degrade cytotoxic granules released from NK cells, and upregulation of PD-1–PD-L1 ligation-suppressed T cell proliferation, autophagy antagonists are pro for anticancer immunity.